These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 9734566

  • 1. Sertindole versus haloperidol for schizophrenia.
    Balon R.
    Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
    [No Abstract] [Full Text] [Related]

  • 2. Sertindole versus haloperidol for schizophrenia.
    Mattes JA.
    Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
    [No Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG, Wozniak P, Mack RJ, McCarthy BG.
    Psychopharmacol Bull; 1998 Sep; 34(1):61-9. PubMed ID: 9564200
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B, Jaanson P, Mittoux A, Tanghøj P, Lis S, Krieger S.
    Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM, Potkin SG, Daniel DG, Buckley PF.
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sertindole : a review of its use in schizophrenia.
    Murdoch D, Keating GM.
    CNS Drugs; 2006 Feb; 20(3):233-55. PubMed ID: 16529528
    [Abstract] [Full Text] [Related]

  • 12. Sertindole for the treatment of schizophrenia.
    Azorin JM, Kaladjian A, Fakra E, Adida M.
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of sertindole in schizophrenia: a clinical review.
    Zoccali RA, Bruno A, Muscatello MR.
    J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sertindole in treating schizophrenia.
    Hosp Med; 1998 Feb; 59(2):165. PubMed ID: 9797900
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.
    Buchsbaum MS, Haznedar M, Newmark RE, Chu KW, Dusi N, Entis JJ, Goldstein KE, Goodman CR, Gupta A, Hazlett E, Iannuzzi J, Torosjan Y, Zhang J, Wolkin A.
    Schizophr Res; 2009 Oct; 114(1-3):161-71. PubMed ID: 19695836
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.